Last updated on November 2017

A study to evaluate the efficacy and safety of E2609 in individuals with early Alzheimer's disease

Brief description of study

The MISSION-AD study is investigating the efficacy and safety of an investigational drug on symptoms of cognitive decline in individuals with mild cognitive impairment or early Alzheimer's disease. The study drug is a tablet which is taken by mouth once per day. The study will last approximately two years.

Eligibility Criteria:

-Attend study visits at Sharp Mesa Vista Hospital's Clinical Research Center
-Have a caregiver (spouse, relative or health care aide) who can accompany you to study visits and help monitor your study progress
-Be 55 to 85 years of age

Other Details:

Participants are reimbursed for time and travel

Clinical Study Identifier: TX133660

Contact Investigators or Research Sites near you

Start Over

Sharp Mesa Vista Hospital Clinical ...

Sharp Mesa Vista Hospital Clinical Research Center
San Diego, CA USA
  Connect »